Testing effectiveness (Phase 2)Study completedNCT00333502
What this trial is testing
Study of CRLX101 (NLG207) in the Treatment of Advanced Solid Tumors
Who this might be right for
CancerSolid Tumor
NewLink Genetics Corporation 62
Showing 20 of 210 results